Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 25 matching records.
25 results — page 1 of 2
- Level DAnimal StudyPubMed
Adipose stem cells ameliorate erectile dysfunction in diabetes mellitus rats by attenuating ferroptosis through NRP1 with SLC7A11 interaction.
Animal Study on Systemic / IV, published in Free Radic Biol Med (2025) — summary generated from the PubMed abstract.
- 2025
Free Radic Biol Med7 citations - Level DNarrative ReviewEurope PMC
Therapeutic Challenges of Diabetes Mellitus-Related Erectile Dysfunction and The Potential Therapeutic Role of Medicinal Plants: A Narrative Review
Narrative Review on Hip, Systemic / IV, published in Drug Des Devel Ther (2025) — summary generated from the PubMed abstract.
- 2025
Drug Des Devel Ther1 citations - Level BClinical TrialPubMed
Current status and advances in adipose-derived stem cells therapy for diabetes mellitus erectile dysfunction.
Clinical Trial on Systemic / IV, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.
- 2025
Front Med (Lausanne) - Level DNarrative ReviewEurope PMC
Erectile Dysfunction in Diabetes Mellitus: A Comprehensive Narrative Review of Pathophysiology, Genetic Association Studies and Therapeutic Approaches
Narrative Review on Systemic / IV, published in Endocrinol Diabetes Metab (2025) — summary generated from the PubMed abstract.
- 2025
Endocrinol Diabetes Metab1 citations - Level DNarrative ReviewEurope PMC
Metabolic Syndrome-Associated Erectile Dysfunction: Multiple Vascular Endothelial Dysfunction Mechanisms and Potential Therapeutic Targets
Narrative Review on Type 2 Diabetes, published in Int J Biol Sci (2025) — summary generated from the PubMed abstract.
- 2025
Int J Biol Sci - Level DNarrative ReviewPubMed
Treatment of erectile dysfunction by intracavernosal administration of mesenchymal stem cells in patients with diabetes mellitus.
Narrative Review on Systemic / IV, published in Int Braz J Urol (2024) — summary generated from the PubMed abstract.
- 2024
Int Braz J Urol6 citations - Level DLaboratory StudyEurope PMC
Current status and prospects of diabetes mellitus induced erectile dysfunction: A bibliometric and visualization study
Laboratory Study on Systemic / IV, published in Front Endocrinol (Lausanne) (2023) — summary generated from the PubMed abstract.
- 2023
Front Endocrinol (Lausanne)7 citations - Level DAnimal StudyEurope PMC
Identification of Key microRNAs in Diabetes Mellitus Erectile Dysfunction Rats with Stem Cell Therapy by Bioinformatic Analysis of Deep Sequencing Data
Animal Study on Systemic / IV, published in World J Mens Health (2022) — summary generated from the PubMed abstract.
- 2022
World J Mens Health6 citations - Level BClinical TrialPubMed
Adipose-Derived Stem Cells from Type 2 Diabetic Rats Retain Positive Effects in a Rat Model of Erectile Dysfunction.
Clinical Trial on Type 2 Diabetes, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci12 citations - Level DNarrative ReviewEurope PMC
Non-Coding RNAs: New Dawn for Diabetes Mellitus Induced Erectile Dysfunction
Narrative Review on Systemic / IV, published in Front Mol Biosci (2022) — summary generated from the PubMed abstract.
- 2022
Front Mol Biosci14 citations - Level CProspective StudyEurope PMC
Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
Prospective Study on Type 1 Diabetes, Type 2 Diabetes, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther78 citations - Level DNarrative ReviewEurope PMC
Role of Glucose-Lowering Medications in Erectile Dysfunction
Narrative Review on Type 2 Diabetes, published in J Clin Med (2021) — summary generated from the PubMed abstract.
- 2021
J Clin Med23 citations - Level DNarrative ReviewPubMed
Stem cell therapy and diabetic erectile dysfunction: A critical review.
Narrative Review on Type 2 Diabetes, published in World J Stem Cells (2021) — summary generated from the PubMed abstract.
- 2021
World J Stem Cells24 citations - Level DNarrative ReviewEurope PMC
Progress and prospect of stem cell therapy for diabetic erectile dysfunction
Narrative Review on Systemic / IV, published in World J Diabetes (2021) — summary generated from the PubMed abstract.
- 2021
World J Diabetes7 citations - Level DAnimal StudyEurope PMC
Exosomes derived from smooth muscle cells ameliorate diabetes-induced erectile dysfunction by inhibiting fibrosis and modulating the NO/cGMP pathway
Animal Study on Systemic / IV, published in J Cell Mol Med (2020) — summary generated from the PubMed abstract.
- 2020
J Cell Mol Med41 citations - Level DAnimal StudyPubMed
Preconditioning of adipose-derived stem cells by phosphodiesterase-5 inhibition enhances therapeutic efficacy against diabetes-induced erectile dysfunction.
Animal Study on Systemic / IV, published in Andrology (2019) — summary generated from the PubMed abstract.
- 2019
Andrology7 citations - Level BRandomized Controlled TrialPubMed
Transplantation of adipose-derived stem cells overexpressing inducible nitric oxide synthase ameliorates diabetes mellitus-induced erectile dysfunction in rats.
Randomized Controlled Trial on Systemic / IV, published in PeerJ (2019) — summary generated from the PubMed abstract.
- 2019
PeerJ8 citations - Level DNarrative ReviewPubMed
Mesenchymal Stem Cells Treatment for Erectile Dysfunction in Diabetic Rats.
Narrative Review on Type 1 Diabetes, published in Sex Med Rev (2019) — summary generated from the PubMed abstract.
- 2019
Sex Med Rev15 citations - Level DAnimal StudyPubMed
Combination of stromal vascular fraction and Ad-COMP-Ang1 gene therapy improves long-term therapeutic efficacy for diabetes-induced erectile dysfunction.
Animal Study on Systemic / IV, published in Asian J Androl (2018) — summary generated from the PubMed abstract.
- 2018
Asian J Androl6 citations - Level DAnimal StudyPubMed
Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction.
Animal Study on Systemic / IV, published in Asian J Androl (2017) — summary generated from the PubMed abstract.
- 2017
Asian J Androl25 citations - Level DAnimal StudyPubMed
Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction.
Animal Study on Face & Skin, Systemic / IV, published in PLoS One (2017) — summary generated from the PubMed abstract.
- 2017
PLoS One43 citations - Level BRandomized Controlled TrialPubMed
Adipose-Derived Stem Cell-Derived Exosomes Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes.
Randomized Controlled Trial on Type 2 Diabetes, published in J Sex Med (2017) — summary generated from the PubMed abstract.
- 2017
J Sex Med85 citations - Level DAnimal StudyEurope PMC
Implanted Muscle-Derived Stem Cells Ameliorate Erectile Dysfunction in a Rat Model of Type 2 Diabetes, but Their Repair Capacity Is Impaired by Their Prior Exposure to the Diabetic Milieu
Animal Study on Type 2 Diabetes, published in J Sex Med (2016) — summary generated from the PubMed abstract.
- 2016
J Sex Med21 citations - Level DAnimal StudyEurope PMC
Treatment of diabetes mellitus-induced erectile dysfunction using endothelial progenitor cells genetically modified with human telomerase reverse transcriptase
Animal Study on Systemic / IV, published in Oncotarget (2016) — summary generated from the PubMed abstract.
- 2016
Oncotarget16 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406